CDK4/6 Inhibitor Resistant Breast Cancer Models
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: In vitro induced Palbociclib resistant MCF-7 cell line...
Continue Reading
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: In vitro induced Palbociclib resistant MCF-7 cell line...
Continue Reading
This webinar will focus on aspects related to PROTAC discovery and chemistry workflows, such as ligand finding strategies, synthesis optimization,...
Continue Reading
This webinar will focus on PROTAC biology workflows, such as in vitro screening assays, in vivo testing, and optimization of...
Continue Reading
https://www.nature.com/articles/s43586-021-00084-5 Abstract DNA-encoded chemical library (DECL) technology is used by the pharmaceutical industry to discover small molecules capable of modulating...
Continue Reading
Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification in the...
Continue Reading
Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past. However, today a variety of...
Continue Reading
Neurological disorders, such as neurodegenerative diseases, epilepsy, chronic pain, psychiatric disorders, are one of today’s largest unmet medical needs. However,...
Continue Reading